Quarterly report pursuant to Section 13 or 15(d)

Inventories, net (Tables)

v3.22.4
Inventories, net (Tables)
6 Months Ended
Nov. 30, 2022
Inventories, net  
Summary of Inventories, net of reserves

Inventories were as follows (in thousands):

​

​

​

​

​

​

​

​

​

November 30, 2022

​

May 31, 2022

Raw materials

​

$

—

​

$

16,264

Work-in-progress

​

 

—

​

 

1,665

Total inventories, net

​

$

—

​

$

17,929

Schedule of remaining shelf life of inventory

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Raw Materials

​

​

Work-in-progress

​

​

​

(in thousands, Expiration period ending November 30,)

    

Remaining shelf-life (mos)

    

Specialized

​

Resins

​

Other

​

Total Raw Materials

​

Bulk drug product

​

Finished drug product

​

Total inventories

2023

​

0 to 12

$

4,764

$

16,264

$

-

$

21,028

​

$

-

​

$

-

​

$

21,028

2024

​

13 to 24

​

2,511

​

-

​

1,590

​

4,101

​

​

1,661

​

​

29,142

​

​

34,904

2025

​

25 to 36

​

189

​

-

​

-

​

189

​

​

-

​

​

32,343

​

​

32,532

2026

​

37 to 48

​

2,115

​

-

​

-

​

2,115

​

​

-

​

​

-

​

​

2,115

Thereafter

​

49 or more

​

-

​

-

​

-

​

-

​

​

-

​

​

-

​

​

-

Inventories, gross

​

​

​

9,579

​

16,264

​

1,590

​

27,433

​

​

1,661

​

​

61,485

​

​

90,579

Inventory charge

​

​

​

(9,579)

​

(16,264)

​

(1,590)

​

(27,433)

​

​

(1,661)

​

​

(61,485)

​

​

(90,579)

Inventories, net

​

​

$

-

$

-

$

-

$

-

​

$

-

​

$

-

​

$

-